Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Private Placement 2024

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Jan 16, 2024 2:37pm

149 Views

Post# 35829674

RE:RE:Private Placement 2024

I do not expect any news other than PP closings before Feb. 8th which is the closing date. What I am wondering is are the powers that be going to run the price up like what happened the last time if you remember? Sell some and buy back in at a lower price to participate which means it should not cost (TFSA) you anything unless that Taxy guy objects. Did the price not hit 11 or 12 before settling back?)

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals